Valuation Alterity Therapeutics

Stocks

Market Closed - Australian S.E. Other stock markets 01:51:59 2026-06-16 EDT			5-day change	1st Jan Change
0.5300 ^AUD	+3.92%		+13.98%	+32.50%

06-09	Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For ATH434 In Multiple System Atrophy	CI
06-03	Alterity Therapeutics Limited Announces Change of Registered Office Address	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	43.75	21.56	11.37	14	59.84	78.57	-	-
Change	-	-50.72%	-47.27%	23.14%	327.48%	31.31%	-	-
Enterprise Value (EV) ¹	43.75	21.56	11.37	9.172	38.2	33.38	37.69	41.47
Change	-	-50.72%	-47.27%	-19.31%	316.5%	-12.61%	12.9%	10.02%
P/E Ratio	-	-	-	-	-	-0.2x	-0.2x	-0.2x
PBR	-	-	-	-	-	-	-	-
PEG	-	-	-	-	-	-	-	-
Capitalization / Revenue	13.3x	6.11x	4.45x	4.81x	11.3x	22.9x	49.1x	24.7x
EV / Revenue	13.3x	6.11x	4.45x	3.15x	7.24x	9.75x	23.6x	13.1x
EV / EBITDA	-	-	-	-0.71x	-4.68x	-2.13x	-1.66x	-1.78x
EV / EBIT	-4.07x	-2.07x	-1.22x	-0.71x	-4.87x	-2.18x	-1.54x	-1.46x
EV / FCF	-	-2.53x	-	-1.07x	-5.11x	-3.19x	-1.73x	-1.94x
FCF Yield	-	-39.6%	-	-93.4%	-19.6%	-31.3%	-57.7%	-51.6%
Dividend per Share ³	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ³	-	-	-	-	-	-2.5	-2.5	-2.5
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3.292	3.528	2.554	2.909	5.278	3.425	1.6	3.177
EBITDA ¹	-	-	-	-12.95	-8.155	-15.64	-22.74	-23.26
EBIT ¹	-10.75	-10.42	-9.321	-12.97	-7.839	-15.32	-24.43	-28.33
Net income ¹	-11.19	-8.843	-8.966	-12.97	-7.927	-13.44	-22.29	-25.74
Net Debt ¹	-	-	-	-4.826	-21.64	-45.19	-40.88	-37.1
Reference price ³	1.4000	0.6500	0.3500	0.2000	0.5000	0.5100	0.5100	0.5100
Nbr of stocks (in thousands)	41,680	48,137	48,798	104,902	182,547	217,508	-	-
Announcement Date	8/31/21	8/31/22	8/31/23	8/29/24	8/28/25	-	-	-